European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease--the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow
- Resource Type
- Article
- Source
- BMJ Open; 7/19/2016, Vol. 6 Issue 7, p1-11, 11p
- Subject
- Language
- ISSN
- 20446055